In the course of time human immunodeficiency virus (HIV) notably affects the host’s immune system. As a result, HIV-infected people can experience awide range of clinical manifestations, especially if the infection is not being treated duly with combination antiretroviral therapy (cART). At such an advanced stage of the disease, patients eventually face severe illnesses. Of these, more than 20 ...

The in vitro effects of isoprinosine (ISO) on interleukin-2 (IL-2) production, the expression of Tac antigen (IL-2 receptor) on lymphocytes, and the ability of Leu 3(+) cells to absorb interleukin-1 (IL-1) were investigated in 10 patients with acquired immune deficiency syndrome (AIDS). In 9 of the 10 patients, production of IL-2 from mononuclear cells and Leu 3(+) cells was depressed; expressi...

To explain a possible pathogenesis of acquired immune deficiency syndrome (AIDS) in homosexual males, we propose the following hypothesis. Prostaglandin E2 in human semen given via anus during anal intercourse may cause an immune dysregulation in the male semen recipients; this immunosuppressive effect of prostaglandin E2 may be one of the underlying factors that stimulate AIDS-associated virus...

During a one month period liver biopsy was carried out on eight patients with established acquired immune deficiency syndrome (AIDS) and two suspected of having AIDS to evaluate raised liver enzymes or unexplained fever and weight loss. Each of the 10 patients were found to have hepatic granulomas. Appropriate staining techniques showed acid-fast bacilli in seven of the liver specimens. One spe...

In an attempt to provide a tool to assess antiretroviral therapy and to monitor disease progression, this article studies association of human immunodeficiency virus (HIV) viral suppression and immune restoration. The data from a recent acquired immune deficiency syndrome (AIDS) study are used for illustration. We jointly model HIV viral dynamics and time to decrease in CD4/CD8 ratio in the pre...

The first descriptions of the acquired immune deficiency syndrome (AIDS) were from the USA in 19811-3 although it is probable the first cases occurred in 1979.2 In Great Britain the first case occurred in 1981.4 In both countries there has been an exponential rise in the numbers of cases. The syndrome is defined by the Center for Diseases Control, Atlanta, Georgia, as characterised by opportuni...

This paper investigates the connection between incarceration dynamics and acquired immune deficiency syndrome (AIDS) infection rates, with particular emphasis on the black-white AIDS rate disparity. Using case-level U.S. data spanning 1982–96, we model the dynamic relationship between AIDS infection rates and the proportion of men in the age-, state-, and race-matched cohort that are incarcerat...